How cancer introduces a paradoxical treatment of chronic pain in America

The difference between my pain and that of a cancer patient is one small word called “non”. If the word “non” is part of my diagnosis, then it unequivocally engenders nearly all facets of my treatment.

Scott Gottlieb’s glib rhetoric won’t stop chronic pain patients from speaking up and asserting their rights.

In a report by Pat Anson published in Pain News Network on July 9, 2018 concerning the FDA Public Hearing with chronic pain patients, a rather cautious hopefulness is expressed in her final remarks: “Unfortunately, the fact remains that there are still too many prescriptions being written for opioids,” FDA commissioner Scott Gottlieb, MD, said …